View Author
plaque patient event circulation disease atherosclerotic factor study heart artery level thrombosis university protein carotid syndrome atherosclerosi death atherosclerotic plaques medicine department blood outcome risk factors fi brous cap marker erasmus mc quartile center lesion table infarction technique vulnerability rupture cardiology intravascular stenosi figure imaging hospital cardiol fuster v coll cardiol school association follow-up future inflammation progression plaque opn levels research assessment culprit naghavi institute 0.9 risk assessment strategies 2.1 opn plaque levels myocardium macrophage cohort development noninvasive artery disease erasmu calci thrombu detection atvb.ahajournals.org serum library downloaded lipid intervention osteopontin thromb atherosclerotic plaque american heart association
5 Most Recent Publications
|
Stabilisation of atherosclerotic plaques position paper of the european society of cardiology (ESC) working group on atherosclerosis and vascular biology
(Article)
Ylä-Herttuala, S. Bentzon, J.F. Marx, N. Naruszewicz, M. Newby, A. Pasterkamp, G. Serruys, P.W.J.C. Waltenberger, J. Weber, C.A. Tokgözoglu, L. Daemen, M.J. Falk, E. Garcia-Garcia, H.M. Herrmann, J. Hoefer, I. Jukema, J.W. Krams, R. Kwak, B.R. |
2011-07-01
|
|
Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events
(Article)
Kleijn, D.P.V. de Moll, F.L. Daemen, M.J. Biessen, E.A.L. Jager, W. de Zhang, H.X. Vries, J.P. de Falk, E. Lim, S.K. Spek, P.J. van der Sze, S.K. Pasterkamp, G. Hellings, W.E. Ozsarlak-Sozer, G. Bruin, P. de Doevendans, P.A. Vink, A. Catanzariti, L.M. Schoneveld, A.H. Algra, A. |
2010-03-01
|
|
Terminology for high-risk and vulnerable coronary artery plaques
(Article)
Schaar, J.A. Muller, J.E. Maseri, A. Steen, A.F.W. van der Falk, E. Virmani, R. Fuster, V. Serruys, P.W.J.C. Colombo, A. Stefanadis, C. Ward Casscells, S. Moreno, P.R. |
2004-06-01
|
|
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
(Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G. |
2003-10-14
|
|
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
(Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G. |
2003-10-07
|
